Source BioScience Healthcare Adds Gastric HER2 Test to Portfolio

Categorised Under:

Source BioScience, a leading provider of histopathology, diagnostic tests and cytology services to the NHS and private hospitals, is pleased to announce the addition of a new Gastric HER2 test to its portfolio of tests. This follows the recent approval by the European Medicines Agency of the use of Herceptin in the treatment of metastatic gastric cancer. Source BioScience is the only laboratory in the UK offering this test.

For more information please go to GASTRIC HER2 test or contact our Business Development Team on +44 (0) 115 79739056.